Page 58 - Vitamin D and Cancer

2 The Molecular Cancer Biology of the VDR 45

33. Efer R, Wagner EF (2003) AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer
3:859–868
34. Watt FM, Frye M, Benitah SA (2008) MYC in mammalian epidermis: how can an oncogene
stimulate differentiation? Nat Rev Cancer 8:234–242
35. Thorne JL, Campbell MJ, Turner BM (2009) Transcription factors, chromatin and cancer. Int
J Biochem Cell Biol 41:164–175
36. Lefterova MI et al (2008) PPAR{gamma} and C/EBP factors orchestrate adipocyte biology
via adjacent binding on a genome-wide scale. Genes Dev 22:2941–2952
37. Lupien M et al (2008) FoxA1 translates epigenetic signatures into enhancer-driven lineage-
specific transcription. Cell 132:958–970
38. Goodson ML, Jonas BA, Privalsky ML (2005) Alternative mRNA splicing of SMRT creates
functional diversity by generating corepressor isoforms with different affinities for different
nuclear receptors. J Biol Chem 280(9):7493–503
39. Jepsen K et al (2007) SMRT-mediated repression of an H3K27 demethylase in progression
from neural stem cell to neuron. Nature 450:415–419
40. Alenghat T et al (2008) Nuclear receptor corepressor and histone deacetylase 3 govern cir-
cadian metabolic physiology. Nature 456(7224):997–1000
41. Astapova I et al (2008) The nuclear corepressor, NCoR, regulates thyroid hormone action
in vivo. Proc Natl Acad Sci USA 105(49):19544–9
42. Sutanto MM, Symons MS, Cohen RN (2007) SMRT recruitment by PPARgamma is medi-
ated by specific residues located in its carboxy-terminal interacting domain. Mol Cell
Endocrinol 267:138–143
43. Polly P et al (2000) VDR-Alien: a novel, DNA-selective vitamin D(3) receptor-corepressor
partnership. FASEB J 14:1455–1463
44. Lykke-Andersen K et al (2003) Disruption of the COP9 signalosome Csn2 subunit in mice
causes deficient cell proliferation, accumulation of p53 and cyclin E, and early embryonic
death. Mol Cell Biol 23:6790–6797
45. Hatchell EC et al (2006) SLIRP, a small SRA binding protein, is a nuclear receptor corepres-
sor. Mol Cell 22:657–668
46. Hsieh JC et al (2003) Physical and functional interaction between the vitamin D receptor and
hairless corepressor, two proteins required for hair cycling. J Biol Chem 278:38665–38674
47. Miller J et al (2001) Atrichia caused by mutations in the vitamin D receptor gene is a phe-
nocopy of generalized atrichia caused by mutations in the hairless gene. J Invest Dermatol
117:612–617
48. Xie Z, Chang S, Oda Y, Bikle DD (2005) Hairless suppresses vitamin D receptor transactiva-
tion in human keratinocytes. Endocrinology 147(1):314–23
49. Scsucova S et al (2005) The repressor DREAM acts as a transcriptional activator on Vitamin
D and retinoic acid response elements. Nucleic Acids Res 33:2269–2279
50. Fujiki R et al (2005) Ligand-induced transrepression by VDR through association of WSTF
with acetylated histones. EMBO J 24:3881–3894
51. Kitagawa H et al (2003) The chromatin-remodeling complex WINAC targets a nuclear
receptor to promoters and is impaired in Williams syndrome. Cell 113:905–917
52. Ding XF et al (1998) Nuclear receptor-binding sites of coactivators glucocorticoid receptor
interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs
with different binding specificities. Mol Endocrinol 12:302–313
53. Eggert M et al (1995) A fraction enriched in a novel glucocorticoid receptor-interacting
protein stimulates receptor-dependent transcription in vitro. J Biol Chem 270:30755–30759
54. Zhang J, Fondell JD (1999) Identification of mouse TRAP100: a transcriptional coregulatory
factor for thyroid hormone and vitamin D receptors. Mol Endocrinol 13:1130–1140
55. Yuan CX, Ito M, Fondell JD, Fu ZY, Roeder RG (1998) The TRAP220 component of a
thyroid hormone receptor- associated protein (TRAP) coactivator complex interacts directly
with nuclear receptors in a ligand-dependent fashion. Proc Natl Acad Sci USA
95:7939–7944